Recent Updates
Recently added Catalysts
HUMA

ALPHA HEALTHCARE ACQUISITION CORP. INDEX TO FINANCIAL STATEMENT Page Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of

Key Takeaway: HEALTHCARE ACQUISITION CORP. TO FINANCIAL STATEMENT Page Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of September 22, 2020 F-3 Notes to Balance Sheet F-4 OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM the Stockholders and Board of Directors

Full Press Release Details

HEALTHCARE ACQUISITION CORP.
TO FINANCIAL STATEMENT
Page
Report of Independent Registered Public Accounting Firm F-2
Balance Sheet as of September 22, 2020 F-3
Notes to Balance Sheet F-4
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
the Stockholders and Board of Directors of
Healthcare Acquisition Corp.
on the Financial Statement
have audited the accompanying balance sheet of Alpha Healthcare Acquisition Corp. (the "Company") as of September
22, 2020, and the related notes (collectively referred to as the "financial statement"). In our opinion, the financial
statement presents fairly, in all material respects, the financial position of the Company as of September 22, 2020 in conformity
with accounting principles generally accepted in the United States of America.
financial statement is the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's
financial statement based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight
Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the
U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statement is free of material misstatement, whether due to error or
fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting.
As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose
of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express
audit included performing procedures to assess the risks of material misstatement of the financial statement, whether due to error
or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statement. Our audit also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statement.
We believe that our audit provides a reasonable basis for our opinion.
have served as the Company's auditor since 2020.
HEALTHCARE ACQUISITION CORP.
Assets:
Cash $ 1,550,000
Prepaid expense 21,200
Total current assets 1,571,200
Cash held in Trust Account 100,000,000
Total assets $ 101,571,200
Liabilities and Stockholders' Equity:
Accrued offering costs $ 238,236
Due to related party 1,667
Promissory note - related party 89,076
Total current liabilities 328,979
Deferred underwriting fee 1,848,103
Total liabilities 2,177,082
Commitments
Class A common stock subject to possible redemption, 9,439,411 shares subject to possible redemption at redemption value 94,394,110
Stockholders' equity:
Preferred shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding -
Class A common stock, $0.0001 par value, 100,000,000 shares authorized, 915,589 shares issued and outstanding 92
Class B common stock, $0.0001 par value, 10,000,000 shares authorized, 2,875,000 shares issued and outstanding (1) 288
Additional paid-in capital 5,002,694
Accumulated deficit (3,066 )
Total stockholders' equity 5,000,008
Total liabilities and stockholders' equity $ 101,571,200
accompanying notes are an integral part of the financial statement.
HEALTHCARE ACQUISITION CORP.
1-Description of Organization and Business Operations
Healthcare Acquisition Corp. (the "Company") was incorporated as a Delaware corporation on July 1, 2020. The
Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses (the "Business Combination"). The Company has not selected
any specific business combination target and the Company has not, nor has anyone on its behalf, initiated any substantive discussions,
directly or indirectly, with any business combination target.
Company has selected December 31 as its fiscal year end.
of September 22, 2020, the Company had not commenced any operations. All activity for the period from July 1, 2020 (inception)
through September 22, 2020 relates to the Company's formation and the Initial Public Offering ("IPO") described
below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at
the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents
from the proceeds derived from the Initial Public Offering
Company's sponsor is AHAC Sponsor, LLC, a Delaware limited liability company (the "Sponsor").
registration statement for the Company's Initial Public Offering was declared effective by the U.S. Securities and Exchange
Commission (the "SEC") on September 17, 2020 (the "Effective Date"). On September 22, 2020, the
Company consummated the Initial Public Offering of 10,000,000 units (the "Units" and, with respect to the shares of
Class A common stock included in the Units sold, the "Public Shares"), at $10.00 per Unit, generating gross proceeds
of $100,000,000, which is described in Note 3.
with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 355,000 private units (the
"Private Placement Units") to the Sponsor, Oppenheimer & Co. Inc. and Northland Securities, Inc. (together, the
"underwriters"), generating gross proceeds to the Company of $3,550,000, which is described in Note 4.
costs amounted to $4,221,956 consisting of $2,000,000 of underwriting discount, $1,848,103 of deferred underwriting fees,
(See Note 6), and $379,713 of other offering costs. In addition, $1,550,000 of cash was held outside of the Trust Account (as
defined below) and is available for working capital purposes.
the closing of the Initial Public Offering on September 22, 2020, an amount of $100,000,000 ($10.00 per Unit) from the net proceeds
of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Units was placed in a trust account
("Trust Account") which will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16)
of the Investment Company Act, with a maturity of 185 days or less or in money market funds meeting certain conditions under
Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations,
until the earlier of: (a) the completion of the Company's initial Business Combination, (b) the redemption of any public
shares properly submitted in connection with a stockholder vote to amend the Company's amended and restated certificate
of incorporation, and (c) the redemption of the Company's public shares if the Company is unable to complete the initial
Business Combination within 24 months from September 22, 2020 (the "Combination Period"), the closing of the
Initial Public Offering.
2-Summary of Significant Accounting Policies
accompanying audited financial statement is presented in U.S. dollars in conformity with accounting principles generally accepted
in the United States of America ("U.S. GAAP") and pursuant to the rules and regulations of the SEC.
Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act of 1933, as amended,
(the "Securities Act"), as modified by the Jumpstart Our Business Startups Act of 2012, (the "JOBS Act"),
and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies
that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation
requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in
its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive
compensation and stockholder approval of any golden parachute payments not previously approved.
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared
effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised
financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt-out of the extended
transition period and comply with the requirements that apply to non-emerging growth companies but any such an election
to opt-out is irrevocable. The Company has elected not to opt-out of such extended transition period, which
means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make the comparison of the Company's financial statement with another public company that is neither an emerging
growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible
because of the potential differences in accounting standards used.
preparation of this financial statement in conformity with U.S. GAAP requires the Company's management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statement.
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect
of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual
results could differ significantly from those estimates.
and cash equivalents
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company did not have any cash equivalents as of September 22, 2020.
Held in Trust Account
September 22, 2020, the assets held in the Trust Account were held in cash.
instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution,
which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At September 22, 2020, the Company has
not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Last updated: Sep 22, 2020